Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0AJ3O
|
|||
Drug Name |
PMID27240464-compound-3f
|
|||
Synonyms |
PMID27240464-C-3f
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) [ICD-11: 1D64] | Preclinical | [1] | |
Severe acute respiratory syndrome (SARS) [ICD-11: 1D65] | Preclinical | [1] | ||
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | MERS-CoV 3C-like proteinase (3CLpro) | Target Info | Inhibitor | [1] |
SARS-CoV 3C-like protease (3CLpro) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. Bioorg Med Chem. 2016 Jul 1;24(13):3035-3042. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.